Not applicableWithdrawnNCT01454687What this trial is testingGrafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous KeratinocytesWho this might be right forEpidermolysis Bullosa Stanford University
Testing effectiveness (Phase 2)Study completedNCT03389308What this trial is testingLong Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa SimplexWho this might be right forEpidermolysis BullosaEpidermolysis Bullosa Simplex Castle Creek Pharmaceuticals, LLC 51
Post-approval studies (Phase 4)Not Yet RecruitingNCT07717736What this trial is testingPhase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of WoundsWho this might be right forEpidermolysis Bullosa (EB)Recessive Dystrophic Epidermolysis Bullosa (RDEB)Dystrophic Epidermolysis Bullosa (DEB) Abeona Therapeutics, Inc 100
Not applicableEnrolling By InvitationNCT06330324What this trial is testingReproductive Options in Inherited Skin DiseasesWho this might be right forIchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more Maastricht University Medical Center 650
Not applicableStudy completedNCT03183934What this trial is testingA Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical TrialWho this might be right forDystrophic Epidermolysis Bullosa Anterogen Co., Ltd. 2
Large-scale testing (Phase 3)Ended earlyNCT01749306What this trial is testingThe Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not HealingWho this might be right forEpidermolysis Bullosa Shire Regenerative Medicine, Inc. 1
Testing effectiveness (Phase 2)Ended earlyNCT03605069What this trial is testingA Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 GeneWho this might be right forEpidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica, Dominant Phoenicis Therapeutics 2
Post-approval studies (Phase 4)WithdrawnNCT00336154What this trial is testingStudy to Evaluate the Efficacy of Tetracycline in Epidermolysis BullosaWho this might be right forEpidermolysis Bullosa Rambam Health Care Campus
Testing effectiveness (Phase 2)Study completedNCT02654483What this trial is testingNeurokinin-1 Receptor Antagonist for the Treatment of Itch in EB PatientsWho this might be right forEpidermolysis BullosaPruritus Jean Yuh Tang 14
Not applicableStudy completedNCT04757727What this trial is testingGynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)Who this might be right forDystrophic Epidermolysis Bullosa Centre Hospitalier Universitaire de Nice 27
Large-scale testing (Phase 3)Active Not RecruitingNCT06073132What this trial is testingAn International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)Who this might be right forGeneralized Epidermolysis Bullosa Simplex TWi Biotechnology, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT02014376What this trial is testingStudy of Effectiveness and Safety of SD-101 in Participants With Epidermolysis BullosaWho this might be right forEpidermolysis Bullosa Scioderm, Inc. 48
Testing effectiveness (Phase 2)UnknownNCT02323789What this trial is testingMesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis BullosaWho this might be right forRecessive Dystrophic Epidermolysis Bullosa King's College London 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649What this trial is testingEmerging Indications for Hyperbaric Oxygen TreatmentWho this might be right forPost-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more Jay C. Buckey Jr. 100
Not applicableLooking for participantsNCT06330350What this trial is testingQualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive CounsellingWho this might be right forQuality of LifeIchthyosisPalmoplantar Keratoses+7 more Maastricht University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT02579369What this trial is testingStudy to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis BullosaWho this might be right forDystrophic Epidermolysis Bullosa Anterogen Co., Ltd. 2
Not applicableStudy completedNCT00004761What this trial is testingEstablishment of the National Epidermolysis Bullosa RegistryWho this might be right forEpidermolysis Bullosa National Center for Research Resources (NCRR)
Not applicableNot Yet RecruitingNCT07684105What this trial is testingTreatment of Dysphagia in Patients With Dystrophic Epidermolysis Bullosa With Budesonide: a Retrospective Bicentric Study Nice - Paris St Louis / Necker (EBUDE Study)Who this might be right forRecessive Dystrophic Epidermolysis BullosaDysphagiaEsophageal Stenosis Centre Hospitalier Universitaire de Nice 15
Not applicableLooking for participantsNCT07700966What this trial is testingA Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing SettingWho this might be right forRecessive Dystrophic Epidermolysis Bullosa Abeona Therapeutics, Inc 250
Large-scale testing (Phase 3)UnknownNCT01340235What this trial is testingTreatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral ErythromycinWho this might be right forEpidermolysis Bullosa Centre Hospitalier Universitaire de Nice 8